로딩 중…
지수 로딩 중…
MiMedx Group, Inc.
MDXG· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.67+1.66%
2026-06-18
Price Chart
MiMedx Group, Inc.-37.80%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $547M |
| Revenue | $389M |
| Net Income | $31M |
| Total Assets | $309M |
| Net Assets | $243M |
| Value | |
| P/E | 17.81x |
| P/B | 2.25x |
| P/S | 1.40x |
| EV/EBITDA | 7.01x |
| FCF Yield | 11.98% |
| Profitability | |
| ROE | 12.63% |
| ROA | 9.94% |
| Op. Margin | 10.17% |
| Revenue Growth | -33.12% |
| Earnings Growth | -254.63% |
| Financial Health | |
| Debt Ratio | 27.06% |
| Total Debt | $2M |
| FCF | $66M |
| Cash | $160M |
| Current Ratio | 5.39x |
| Net Debt/EBITDA | -2.86x |
| Performance | |
| 1Y Return | -37.80% |
| 1M Return | 0.82% |
| From 52W High | -54.07% |
| 1Y MDD | -61.18% |
| Trading | |
| Volume | 1,787,744 shares |
| Trading Value | $7M |
| Per Share | |
| EPS | $0.33 |
| BPS | $1.74 |